Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1



Capper, Michael, O'Neill, Paul ORCID: 0000-0003-4338-0317, Fisher, Nicholas, Strange, Richard, Moss, Darren, Ward, Stephen, Berry, Neil ORCID: 0000-0003-1928-0738, Lawrenson, Alexandre, Hasnain, Samar, Biagini, Giancarlo
et al (show 1 more authors) (2015) Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1. Proceedings of the National Academy of Sciences of the United States of America, 112 (3). 755 - 760.

[img] Text
PNAS-2015-Capper-755-60.pdf - OA Published Version

Download (1MB)

Abstract

Cytochrome bc1 is a proven drug target in the prevention and treatment of malaria. The rise in drug-resistant strains of Plasmodium falciparum, the organism responsible for malaria, has generated a global effort in designing new classes of drugs. Much of the design/redesign work on overcoming this resistance has been focused on compounds that are presumed to bind the Q(o) site (one of two potential binding sites within cytochrome bc1 using the known crystal structure of this large membrane-bound macromolecular complex via in silico modeling. Cocrystallization of the cytochrome bc1 complex with the 4(1H)-pyridone class of inhibitors, GSK932121 and GW844520, that have been shown to be potent antimalarial agents in vivo, revealed that these inhibitors do not bind at the Q(o) site but bind at the Q(i )site. The discovery that these compounds bind at the Q(i) site may provide a molecular explanation for the cardiotoxicity and eventual failure of GSK932121 in phase-1 clinical trial and highlight the need for direct experimental observation of a compound bound to a target site before chemical optimization and development for clinical trials. The binding of the 4(1H)-pyridone class of inhibitors to Q(i) also explains the ability of this class to overcome parasite Q(o)-based atovaquone resistance and provides critical structural information for future design of new selective compounds with improved safety profiles.

Item Type: Article
Uncontrolled Keywords: Plasmodium falciparum, cytochrome bc1, drug discovery, malaria, membrane protein
Subjects: ?? Q1 ??
Depositing User: Symplectic Admin
Date Deposited: 30 Mar 2015 09:17
Last Modified: 10 Jun 2022 01:13
DOI: 10.1073/pnas.1416611112
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/2009222